The antihypoxia-adenosinergic pathogenesis as a result of collateral damage by overactive immune cells

Journal of Leukocyte Biology

Volumn 86, Issue 3, 2009, Pages 545-548

  Hatfield, Stephen ^a   Belikoff, Bryan ^b   Lukashev, Dmitriy ^a   Sitkovsky, Michail ^a   Ohta, Akio ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine receptors; Caffeine; HIF 1 ; Hypoxia; Inflammation; Oxygen; T cells

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ACUTE LUNG INJURY; HYPOXIA; IMMUNOCOMPETENT CELL; LUNG PARENCHYMA; NONHUMAN; OXYGENATION; PNEUMONIA; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE;

ACUTE LUNG INJURY; ADENOSINE; ADENOSINE A2 RECEPTOR ANTAGONISTS; ANIMALS; ANOXIA; CAFFEINE; DISEASE MODELS, ANIMAL; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; MICE; MICE, MUTANT STRAINS; OXYGEN; OXYGEN CONSUMPTION; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; RESPIRATORY DISTRESS SYNDROME, ADULT; T-LYMPHOCYTES, REGULATORY;

ANIMALIA;

EID: 70149095024     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0908577     Document Type: Short Survey

References (43)

1. Peggs, K. S., Segal, N. H., Allison, J. P. (2007) Targeting immunosupportive cancer therapies: accentuate the positive, eliminate the negative. Cancer Cell 12, 192-199.
2. Ohta, A., Sitkovsky, M. (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414, 916-920. (Pubitemid 34024743)
3. Sitkovsky, M. V., Lukashev, D., Apasov, S., Kojima, H., Koshiba, M., Caldwell, C., Ohta, A., Thiel, M. (2004) Physiological control of immune response and inflammatory tissue damage by hypoxia inducible factors and adenosine A2A receptors. Annu. Rev. Immunol. 22, 2101-2126. (Pubitemid 38680437)
4. Sitkovsky, M. V., Ohta, A. (2005) The "danger" sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol. 26, 299-304.
5. Sitkovsky, M., Lukashev, D. (2005) Regulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors. Nat. Rev. Immunol. 5, 712-721. (Pubitemid 43086172)
6. Lukashev, D., Caldwell, C., Ohta, A., Chen, P., Sitkovsky, M. (2001) Differential regulation of two alternatively spliced isoforms of hypoxia-inducible factor-1 α in activated T lymphocytes. J. Biol. Chem. 276, 48754-48763. (Pubitemid 37370572)
7. Lukashev, D., Klebanov, B., Kojima, H., Grinberg, A., Ohta, A., Berenfeld, L., Wenger, R. H., Sitkovsky, M. (2006) Cutting edge: hypoxia-inducible factor 1α and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes. J. Immunol. 177, 4962-4965. (Pubitemid 44527564)
8. Thiel, M., Caldwell, C. C., Kreth, S., Kuboki, S., Chen, P., Smith, P., Ohta, A., Lentsch, A. B., Lukashev, D., Sitkovsky, M. V. (2007) Targeted deletion of HIF-1α gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS ONE 2, e853.
9. Kojima, H., Gu, H., Nomura, S., Caldwell, C. C., Kobata, T., Carmeliet, P., Semenza, G. L., Sitkovsky, M. V. (2002) Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1α -deficient chimeric mice. Proc. Natl. Acad. Sci. USA 99, 2170-2174. (Pubitemid 34169033)
10. Koshiba, M., Kojima, H., Huang, S., Apasov, S., Sitkovsky, M. V. (1997) Memory of extracellular adenosine/A2a purinergic receptor-mediated signaling in murine T cells. J. Biol. Chem. 272, 25881-25889. (Pubitemid 27438913)
11. Huang, S., Koshiba, M., Apasov, S., Sitkovsky, M. (1997) Role of A2a adenosine receptor-mediated signaling in inhibition of T cell activation and expansion. Blood 90, 1600-1610.
12. Semenza, G. L. (1998) Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr. Opin. Genet. Dev. 8, 588-594. (Pubitemid 28477364)
13. Semenza, G. L. (1999) Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15, 551-578. (Pubitemid 32250386)
14. Carmeliet, P., Dor, Y., Herbert, J. M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., Koch, C. J., Ratcliffe, P., Moons, L., Jain, R. K., Collen, D., Keshert, E. (1998) Role of HIF-1 α in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature 394, 485-490. (Pubitemid 28373960)
15. Rosenberger, P., Schwab, J. M., Mirakaj, V., Masekowsky, E., Mager, A., Morote-Garcia, J. C., Unertl, K., Eltzschig, H. K. (2009) Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat. Immunol. 10, 195-202.
16. Decking, U. K., Schlieper, G., Kroll, K., Schrader, J. (1997) Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release. Circ. Res. 81, 154-164. (Pubitemid 27342482)
17. Morote-Garcia, J. C., Rosenberger, P., Kuhlicke, J., Eltzschig, H. K. (2008) HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 111, 5571-5580.
18. Sitkovsky, M. V. (2008) Damage control by hypoxia-inhibited AK. Blood 111, 5424-5425.
19. Eltzschig, H. K., Eckle, T., Mager, A., Kuper, N., Karcher, C., Weissmuller, T., Boengler, K., Schulz, R., Robson, S. C., Colgan, S. P. (2006) ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ. Res. 99, 1100-1108. (Pubitemid 44729934)
20. Robson, S. C., Wu, Y., Sun, X., Knosalla, C., Dwyer, K., Enjyoji, K. (2005) Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin. Thromb. Hemost. 31, 217-233. (Pubitemid 40605196)
21. Thompson, L. F., Eltzschig, H. K., Ibla, J. C., Van De Wiele, C. J., Resta, R., Morote-Garcia, J. C., Colgan, S. P. (2004) Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200, 1395-1405. (Pubitemid 39657287)
22. Fredholm, B. B., Ijzerman, A. P., Jacobson, K. A., Klotz, K-N., Linden, J. (2001) International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors. Pharmacol. Rev. 53, 527-552.
23. Fredholm, B. B., Battig, K., Holmen, J., Nehlig, A., Zvartau, E. E. (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51, 83-133. (Pubitemid 29113867)
24. Linden, J. (2001) Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol. 41, 775-787. (Pubitemid 32385906)
25. Jacobson, K. A., Gao, Z. G. (2006) Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 5, 247-264.
26. Cronstein, B. N., Daguma, L., Nichols, D., Hutchison, A., Williams, M. (1990) The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. J. Clin. Invest. 85, 1150-1157. (Pubitemid 20123757)
27. Sitkovsky, M. V. (2003) Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo. Biochem. Pharmacol. 65, 493-501. (Pubitemid 36144234)
28. Koshiba, M., Rosin, D. L., Hayashi, N., Linden, J., Sitkovsky, M. V. (1999) Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. Mol. Pharmacol. 55, 614-624. (Pubitemid 29128120)
29. Takayama, H., Sitkovsky, M. V. (1989) Potential use of antagonists of cAMP-dependent protein kinase to block inhibition and modulate T-cell receptor-triggered activation of cytotoxic T-lymphocytes. J. Pharm. Sci. 78, 8-10. (Pubitemid 19079802)
30. Sugiyama, H., Chen, P., Hunter, M., Taffs, R., Sitkovsky, M. (1992) The dual role of the cAMP-dependent protein kinase C α subunit in T-cell receptor-triggered T-lymphocytes effector functions. J. Biol. Chem. 267, 25256-25263.
31. Torgersen, K. M., Vang, T., Abrahamsen, H., Yaqub, S., Tasken, K. (2002) Molecular mechanisms for protein kinase A-mediated modulation of immune function. Cell. Signal. 14, 1-9. (Pubitemid 34020823)
32. Sun, H., Gutierrez, P., Jackson, M. J., Kundu, N., Fulton, A. M. (2000) Essential role of nitric oxide and interferon-γ for tumor immunotherapy with interleukin-10. J. Immunother. 23, 208-214. (Pubitemid 30165170)
33. Poehlein, C. H., Hu, H. M., Yamada, J., Assmann, I., Alvord, W. G., Urba, W. J., Fox, B. A. (2003) TNF plays an essential role in tumor regression after adoptive transfer of perforin/IFN-γ double knockout effector T cells. J. Immunol. 170, 2004-2013. (Pubitemid 36197421)
34. Semenza, G. L. (2003) Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732.
35. Krishnamachary, B., Berg-Dixon, S., Kelly, B., Agani, F., Feldser, D., Ferreira, G., Iyer, N., LaRusch, J., Pak, B., Taghavi, P., Semenza, G. L. (2003) Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 63, 1138-1143. (Pubitemid 36278449)
36. Caldwell, C. C., Kojima, H., Lukashev, D., Armstrong, J., Farber, M., Apasov, S. G., Sitkovsky, M. V. (2001) Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J. Immunol. 167, 6140-6149. (Pubitemid 33081540)
37. Thiel, M., Chouker, A., Ohta, A., Jackson, E., Caldwell, C., Smith, P., Lukashev, D., Bittmann, I., Sitkovsky, M. V. (2005) Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol. 3, e174. (Pubitemid 41032218)
38. Fredholm, B. B. (1995) Adenosine, adenosine receptors and the actions of caffeine. Pharmacol. Toxicol. 76, 93-101.
39. Fredholm, B. B., Chern, Y., Franco, R., Sitkovsky, M. (2007) Aspects of the general biology of adenosine A2A signaling. Prog. Neurobiol. 83, 263-276. (Pubitemid 350102746)
40. Ohta, A., Lukashev, D., Jackson, E. K., Fredholm, B. B., Sitkovsky, M. (2007) 1,3,7-Trimethylxanthine (caffeine) may exacerbate acute inflammatory liver injury by weakening the physiological immunosuppressive mechanism. J. Immunol. 179, 7431-7438.
41. Buras, J. A., Holzmann, B., Sitkovsky, M. (2005) Animal models of sepsis: setting the stage. Nat. Rev. Drug Discov. 4, 854-865.
42. Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D., Wong, M. K., Huang, X., Caldwell, S., Liu, K., Smith, P., Chen, J. F., Jackson, E. K., Apasov, S., Abrams, S., Sitkovsky, M. (2006) A2A adenosine receptor protects tumors from antitumor T cells. Proc. Natl. Acad. Sci. USA 103, 13132-13137. (Pubitemid 44338928)
43. 2A receptor inactivation increases survival in polymicrobial sepsis. J. Immunol. 176, 5616-5626.